Does vaping cause cancer
Pro Research Analysisby 
Searched over 200M research papers
Vaping and Cancer Risk: A Comprehensive Review
Introduction to Vaping and Cancer Risk
Vaping, the use of electronic cigarettes (e-cigarettes) to inhale vaporized nicotine and other substances, has gained popularity as an alternative to traditional smoking. However, concerns about its potential health risks, particularly its association with cancer, have been rising. This article synthesizes current research on the potential oncogenic effects of vaping.
Oncogenic Compounds in E-Cigarettes
Presence of Carcinogens
E-cigarette devices and vaping fluids contain several known and probable carcinogens. These include nicotine derivatives such as nitrosnornicotine and nitrosamine ketone, polycyclic aromatic hydrocarbons, heavy metals, and aldehydes like formaldehyde, which is formed from the pyrolysis of glycerol 12. These compounds have been shown to have transforming and cytotoxic activities in vitro, raising concerns about their potential to cause cancer in humans .
Comparison with Traditional Cigarettes
While e-cigarettes generally produce fewer carcinogenic compounds than traditional cigarettes, they are not free from risk. The cancer potencies of e-cigarette emissions span a wide range, with most products having significantly lower potencies than tobacco smoke. However, some e-cigarettes, especially those delivering excessive power to the atomizer coil, can produce high levels of harmful carbonyls, increasing their cancer risk .
Mechanisms of Oncogenesis
Molecular Mechanisms
Several molecular mechanisms have been proposed for the oncogenic impact of vaping. These include epithelial-mesenchymal transition, redox stress, mitochondrial toxicity, and DNA breaks and fragmentation . Additionally, vaping has been shown to cause immune dysregulation similar to that caused by conventional cigarette smoke, potentially contributing to cancer development .
Immune Dysregulation
Research indicates that vaping can upregulate immune-associated genes such as Osteopontin (OPN), which is involved in regulating the EGFR and CD44 signaling cascades. This upregulation has been correlated with poorer prognosis in various smoking-induced cancers, suggesting a similar potential for vaping-induced cancers .
Epidemiological Evidence
Case Studies and Population Data
There are documented cases where vaping has been associated with severe health issues mimicking cancer. For instance, a case report described a 45-year-old female who developed pulmonary nodules and liver lesions initially suspected to be metastatic cancer, which regressed upon cessation of e-cigarette use . Additionally, a young adult with extensive vaping history was diagnosed with rapidly progressive and fatal HPV-negative squamous cell carcinoma of the oropharynx .
Second-Hand Exposure
Second-hand exposure to e-cigarette aerosols also poses a risk, albeit significantly lower than that from traditional cigarettes. The excess life cancer risk (ELCR) for passive vapers is much lower compared to passive smokers, but it is not negligible .
Conclusion
While vaping is generally considered less harmful than traditional smoking, it is not without risks. E-cigarettes contain several carcinogenic compounds, and their use has been associated with molecular changes and immune dysregulation that could potentially lead to cancer. The long-term health implications of vaping are still not fully understood, and further research is warranted to elucidate the mechanisms and extent of its oncogenic potential. Given the current evidence, caution and tighter regulation of e-cigarette products are advisable to mitigate potential public health risks.
Sources and full results
Most relevant research papers on this topic